Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study

炎症、衰老、微生物、阻塞性肺病和扩散异常 (I AM OLD-DA) 研究

基本信息

  • 批准号:
    10798953
  • 负责人:
  • 金额:
    $ 5.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT Chronic obstructive pulmonary disease (COPD) is an HIV-associated lung disease and a leading cause of morbidity and mortality, and its clinical significance is increasing as the HIV+ population ages worldwide. Despite this, our understanding of the mechanisms underlying HIV+ COPD is limited but both HIV-related and COPD- specific mechanisms are hypothesized. An improved understanding is critical for developing new therapies to treat or prevent this growing problem. This study builds upon a novel, established multinational (US and Uganda) cohort of HIV+ persons. The study measured selected markers of immune activation, inflammation, lung injury, and cellular aging in both blood and lung specimens. The study also performed lung function testing and examined the associations between the selected markers and lung function. Our data show that different markers are associated with different lung function abnormalities, suggesting that these lung function abnormalities may be due to different underlying mechanisms. Interestingly, cytomegalovirus (CMV), which is a chronic viral infection common in HIV+ persons, has been associated with the three markers most strongly associated with one of the lung function abnormalities. These data lead to the following specific aims: Aims 1 and 2: To test the hypothesis that persistent abnormalities in selected markers of immune activation, inflammation, lung injury, and cellular aging measured in the blood are associated with subsequent changes (declines) in lung function and that the specific markers associated with each lung function abnormality will be different. The longitudinal study design will strengthen the causal inferences from our earlier work and will set the foundation for future trials of therapeutic interventions, including the potential for personalized medicine with potentially novel and/or different therapies for different biomarker and/or different lung function abnormalities. Aim 3. In a cross-sectional subset of HIV+ participants selected to undergo bronchoscopy and collect lung specimens, to test the hypothesis that abnormalities in the same markers but now measured in lung specimens are associated with abnormal lung function and test the hypothesis that asymptomatic CMV co-infection is also associated with lung function abnormalities and is mediated by these markers. This aim will determine whether CMV co-infection is involved in lung function abnormalities and potentially set the stage for trials of anti-CMV therapy in HIV+ COPD. To address these aims, we will conduct a longitudinal study of 400 HIV+ subjects (200 in the US and 200 in Uganda) and collect and bank blood specimens at the same time as lung function testing. We will also perform bronchoscopy in a subset of 80 subjects (40 in the US and 40 in Uganda) and collect and bank lung specimens and specimens to assess for CMV co-infection at the same time as lung function testing. The banked specimens will allow for efficient testing of new and novel markers in the future. Our long-term objective is to improve our mechanistic understanding of lung function abnormalities seen in persons with HIV that would lead to a future study that tests new treatments for this important and growing clinical problem.
摘要

项目成果

期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda.
  • DOI:
    10.1128/spectrum.00860-22
  • 发表时间:
    2022-10-26
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Byanyima, Patrick;Kaswabuli, Sylvia;Musisi, Emmanuel;Nabakiibi, Catherine;Zawedde, Josephine;Sanyu, Ingvar;Sessolo, Abdul;Andama, Alfred;Worodria, William;Huang, Laurence;Davis, J. Lucian
  • 通讯作者:
    Davis, J. Lucian
Reproducibility of the Ribosomal RNA Synthesis Ratio in Sputum and Association with Markers of Mycobacterium tuberculosis Burden.
  • DOI:
    10.1128/spectrum.00481-21
  • 发表时间:
    2021-10-31
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Musisi E;Dide-Agossou C;Al Mubarak R;Rossmassler K;Ssesolo AW;Kaswabuli S;Byanyima P;Sanyu I;Zawedde J;Worodria W;Voskuil MI;Savic RM;Nahid P;Davis JL;Huang L;Moore CM;Walter ND
  • 通讯作者:
    Walter ND
HIV Infection Is Associated with Shortened Telomere Length in Ugandans with Suspected Tuberculosis.
  • DOI:
    10.1371/journal.pone.0163153
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Auld E;Lin J;Chang E;Byanyima P;Ayakaka I;Musisi E;Worodria W;Davis JL;Segal M;Blackburn E;Huang L
  • 通讯作者:
    Huang L
HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumonia.
乌干达成人肺炎患者的免疫激活生物标志物升高与艾滋病毒感染有关。
  • DOI:
    10.1371/journal.pone.0216680
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Wang,RichardJ;Moore,Julia;Moisi,Daniela;Chang,EmilyG;Byanyima,Patrick;Kaswabuli,Sylvia;Musisi,Emmanuel;Sanyu,Ingvar;Sessolo,Abdulwahab;Lalitha,Rejani;Worodria,William;Davis,JLucian;Crothers,Kristina;Lin,Jue;Lederman,Michael
  • 通讯作者:
    Lederman,Michael
Stress and telomere shortening: Insights from cellular mechanisms.
  • DOI:
    10.1016/j.arr.2021.101507
  • 发表时间:
    2022-01
  • 期刊:
  • 影响因子:
    13.1
  • 作者:
    Lin J;Epel E
  • 通讯作者:
    Epel E
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAURENCE HUANG其他文献

LAURENCE HUANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAURENCE HUANG', 18)}}的其他基金

Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study
阻塞性肺疾病(I AM GOLD)研究中微生物和基因组数据的综合分析
  • 批准号:
    10017311
  • 财政年份:
    2019
  • 资助金额:
    $ 5.31万
  • 项目类别:
Enhancing the I AM GOLD study with single-cell deep phenotyping and machine learning meta-analysis
通过单细胞深度表型分析和机器学习荟萃分析加强 I AM GOLD 研究
  • 批准号:
    10177730
  • 财政年份:
    2019
  • 资助金额:
    $ 5.31万
  • 项目类别:
Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study
阻塞性肺疾病(I AM GOLD)研究中微生物和基因组数据的综合分析
  • 批准号:
    10446574
  • 财政年份:
    2019
  • 资助金额:
    $ 5.31万
  • 项目类别:
UCSF Career Development Program in Cardiopulmonary, Hematologic, and Immunologic Comorbidities of HIV (CHIC)
加州大学旧金山分校艾滋病心肺、血液和免疫合并症职业发展计划 (CHIC)
  • 批准号:
    9753769
  • 财政年份:
    2018
  • 资助金额:
    $ 5.31万
  • 项目类别:
UCSF Career Development Program in Cardiopulmonary, Hematologic, and Immunologic Comorbidities of HIV (CHIC)
加州大学旧金山分校艾滋病心肺、血液和免疫合并症职业发展计划 (CHIC)
  • 批准号:
    10413803
  • 财政年份:
    2018
  • 资助金额:
    $ 5.31万
  • 项目类别:
UCSF Career Development Program in Cardiopulmonary, Hematologic, and Immunologic Comorbidities of HIV (CHIC)
加州大学旧金山分校艾滋病心肺、血液和免疫合并症职业发展计划 (CHIC)
  • 批准号:
    10202714
  • 财政年份:
    2018
  • 资助金额:
    $ 5.31万
  • 项目类别:
Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study
炎症、衰老、微生物、阻塞性肺疾病和扩散异常 (I AM OLD-DA) 研究
  • 批准号:
    10014578
  • 财政年份:
    2015
  • 资助金额:
    $ 5.31万
  • 项目类别:
Inflammation, Aging, Microbes, Obstructive Lung Disease, and Diffusion Abnormalities (I AM OLD-DA): Pulmonary function in females, evaluating the menopausal transition and immune activation (pFEMI).
炎症、衰老、微生物、阻塞性肺疾病和扩散异常 (I AM OLD-DA):女性肺功能,评估绝经过渡和免疫激活 (pFEMI)。
  • 批准号:
    10556269
  • 财政年份:
    2015
  • 资助金额:
    $ 5.31万
  • 项目类别:
Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study
炎症、衰老、微生物、阻塞性肺疾病和扩散异常 (I AM OLD-DA) 研究
  • 批准号:
    10588459
  • 财政年份:
    2015
  • 资助金额:
    $ 5.31万
  • 项目类别:
Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study
炎症、衰老、微生物、阻塞性肺疾病和扩散异常 (I AM OLD-DA) 研究
  • 批准号:
    10613550
  • 财政年份:
    2015
  • 资助金额:
    $ 5.31万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了